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570 020, IndiaConsiderable progress in carotenoids research has been made
to understand the carotenoid metabolism in animals including
human. Epidemiological and clinical studies have correlated
with dietary intake of carotenoids on reduction of vitamin A
deficiency, age-related macular degeneration, cancer and car-
diovascular diseases. Recent findings demonstrate the exis-
tence of carotenoid metabolites in vivo and their efficacy
have made greater insight on prospecting carotenoid metabo-
lites. Owing to their biological activity, exploration of analyt-
ical methods for the characterization of carotenoid
metabolites is considered to be important before addressing
the stability and bioactivity. Although few studies are available
on carotenoid metabolites, their structural characterization in
biological samples require a substantial refining of analytical
protocols like isolation, purification, prerequisite of equipment
parameters and robustness in hyphenated techniques.Recently, researchers have focused on biotransformation of ca-
rotenoids and made an attempt to screen their metabolites by
high-throughput analytical strategies. However, till date there
is no detailed analytical techniques available to fingerprint
carotenoid metabolites, due to interference with complex bio-
logical matrices. This review highlights the carotenoid meta-
bolism, possible bioconversion and available bio-analytical
techniques to characterize metabolites in vivo. Further,
advancement in sensitivity, mode of ionization and fragmenta-
tion patterns of metabolites were also discussed. The identifi-
cation of carotenoid metabolites in system specific will have
further insight in the emerging field of nutritional
metabolomics.Introduction
Carotenoids are pigments with a wide range of spectrum
consisting of C40 backbone (Britton et al., 1997; Polıvka
& Frank, 2010). Fruits and vegetables (Sommerburg,
Keunen, Bird, & van Kuijk, 1998; Raju, Varakumar,
Lakshminarayana, Krishnakantha, & Baskaran, 2007), ani-
mal products, marine algae, and certain seaweeds are good
sources of carotenoids (Britton, Liaaen-Jensen, & Pfander,
2009). Generally, carotenoids are classified as carotenes
(carotenoid hydrocarbons) composed of only carbon and
hydrogen (b-carotene and lycopene) and xanthophylls
(oxygenated carotenoids), which contain an epoxy- (viola-
xanthin, neoxanthin, fucoxanthin), hydroxy- (lutein and
zeaxanthin), keto- (astaxanthin, canthaxanthin) and me-
thoxy- (spirilloxanthin) functional groups. In case of nutri-
tional approach, carotenoids are considered to be an
important bioactive compounds, and dietary ingestion is
the only source to meet their requirement in humans and
animals. Approximately, 750 carotenoids have been
described in nature, 50 of them are identified in the human
diet and more than 20 are detected in the human blood and
tissues (Khachik, 2006). Among carotenoids, b-carotene, a-
carotene, lycopene, lutein, zeaxanthin and b-cryptoxanthin
are the most common carotenoids found in the human diet,
blood and tissues (Khachik, Spangler, & Cecil Smith,
1997). Several epidemiological and clinical trials have
well correlated the consumption of dietary carotenoids
with decreased risk of vitamin A deficiency, cancer, cardio-
vascular diseases (CVD) and age-related macular degener-
ation (AMD) (Dıaz, de las Cagigas, & Rodriguez, 2003;
Rock, 2009; Kohlmeier & Hastings, 1995; Bone,
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tene and b-cryptoxanthin are known precursors of vitamin
A (Bendich & Olson, 1989). The other non-pro vitamin
A carotenoid such as lycopene has gained special attention,
and many studies have correlated its role in the reduction of
prostate cancers (Giovannucci, 2005; Talvas et al., 2010).
Lutein and zeaxanthin are considered as a vital macular
pigments located in central region of retina, acts as filter
of high-energy blue light, quenchers of singlet oxygen,
chain-breaking antioxidants and involve in the reduction
of phototoxic damage to the eye (Bone et al., 2003). Astax-
anthin, fucoxanthin, siphonaxanthin are other promising
marine carotenoids combat with health associated benefits
as bioactive molecules against diabetes, obesity, angiogen-
esis (Higuera-Ciapara, Felix-Valenzuela, & Goycoolea,
2006; Sachindra et al., 2007; Kim, Heo, Kang, Ahn, &
Jeon, 2010; Woo et al., 2009; Ganesan et al., 2011).
Although bioavailability and functionality of carotenoids
are addressed knowledge on metabolomics of carotenoids
and bioefficacy of those metabolites are not detailed.
Therefore, characterization of carotenoid metabolites pro-
vide a broad scope for molecular nutrition. Further,
improvement in analytical techniques to resolve the unex-
plored carotenoid metabolites in vivo requires a sensitive
and rapid analysis. Carotenoid metabolites may involve in
a specific intrinsic biological activity. Hence, currently me-
tabolomics is preferably positioned in many areas of food
science and nutrition research, especially consumption
and physiological monitoring of carotenoids in interven-
tional studies. Owing to the necessity for the improved
analytical techniques to characterize carotenoid and their
metabolites, hyphenated techniques were used to analyze
biological and physiological samples. Currently, such
methods are considered to be most promising tools in carot-
enoids biochemistry (Dueker, Jones, Smith, & Clifford,
1994; Hagiwara, Yasuno, Funayama, & Suzuki, 1998;
Fraser, Enfissi, Goodfellow, Eguchi, & Bramley, 2007).
Developing such advanced techniques is essential, since
the emerging metabolomics concept in many natural com-
ponents is the integrated part of proteomics, genomics, and
lipidomics. Under the umbrella of lipidomics, here we have
attempted to build the knowledge on “metabolomics”.
Therefore, this review highlights the profiling of caroten-
oids metabolism in animals and related hyphenated analyt-
ical techniques are discussed.
Trends in carotenoids metabolism and profiling of
their metabolites in animals and human
Knowledge on carotenoid metabolism in humans and
their biological significance has become important in nutri-
tion and pharmacological research. The characterization of
centric/eccentric cleavages, the formation of apocarote-
noids, and oxidative products of pro-vitamin and non-
provitamin A carotenoids is given a platform for metabolo-
mics. As evident from available research reports, caroten-
oids are biologically converted into metabolites byenzymatic cleavages, oxidation, reduction, hydrolysis and
by active reaction with free radicals (Olson, 1994; Nagao,
2004; Lakshminarayana et al., 2008) (Fig. 1). This raised
an important question, whether intact carotenoids are
involved in diverse cellular functions or its metabolites.
Many studies, including our own, support the concept of
biological functions are mediated by carotenoid metabolites
(Stahl, von Laar, Martin, Emmerich, & Sies, 2000; Lian,
Smith, Ernst, Russell, & Wang, 2007; Nidhi, Sharavana,
Ramaprasad, & Baskaran, 2014; Lakshminarayana,
Aruna, Sathisha, Dharmesh, & Baskaran, 2013). However,
there are evidence that reveal, cleavage products of b-caro-
tene is harmful to smokers when supplemented with high
doses (Omenn, Goodman, & Thomquist, 1996). Hence,
occurrence and assessment of carotenoids cleavage prod-
ucts is crucial to conclude their bioactivity. The carotenoids
level in the biological samples are detected below nanomo-
lar concentration, analyzed routinely by HPLC (Khachik
et al.,1997; Stahl et al., 2000). Further, determination of
carotenoid metabolites that exist at picomolar concentration
is really a major task. In this context, several studies have
attempted for the detection of major carotenoid metabolites
in vivo by using different hyphenated analytical methods
Table 1. The formation, occurrence and understanding of
specific bioactivity of carotenoid metabolites are exciting
and challenging. Hence, this section illustrates the possible
metabolism of major carotenoids.
To increase our understanding of the above aspects and
also to know the key role of carotenoids metabolites, we
need greater insight on their bioavailability. However,
many of the bioavailability studies are based on the mea-
surement of intact carotenoids either in the blood or tissues
or excretory products but not their metabolites, except for
b-carotene. Hence, characterization and quantification of
carotenoid metabolites is also necessary to estimate the
real levels of carotenoid bioavailability. Carotenoid iso-
mers/oxidative products/metabolites possibly form during
food processing, digestion, absorption, transportation and
the site of accumulations. The detailed possible stages of
degradation, biotransformation and biological functions of
carotenoids are hypothetically described under the concept
of metabolomics (Fig. 1).
Metabolism of hydrocarbon carotenes
In animals, b-carotene conversion to vitamin A was first
reported in the rat model (Moore, 1930). Later, the structure
was elucidated and demonstrated the central cleavage of b-
carotene at the central carbon double bond (15, 150) leads to
the retinal formation (Olson, 1994). Harrison, Dela Sena,
Eroglu, and Fleshman (2012) reported eccentric cleavage
of b-carotene to retinoic acid via b-apo-carotenoic acid.
Eroglu and Harrison (2013) have detailed the pathways of
centric and eccentric cleavages of b-carotene in vertebrates.
Central cleavage of b-carotene yields two molecules of
retinal followed by oxidation to form retinoic acid. In
case of eccentric cleavage of b-carotene, b-apocarotenals
Fig. 1. Overview of carotenoid metabolism and hypothetical vision of metabolomics approach.
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focused on the responsible enzyme for the central cleavage
of b-carotene, a-carotene, and b-cryptoxanthin (Olson,
1989; van Vliet, van Schaik, Schreurs, & van Den, 1996).
Later, Lindquist and Anderson (2002) have shown b-caro-
tene mammalian b-carotene-15,150-oxygenase (BCMO1)
enzyme acts at 15,150 double bond of provitamin A carot-
enoids in mammals. Further, they have demonstrated that
BCMO1 requires at least one nonsubstituted b-ionone
ring to yield retinal. In addition, peroxidases and lipoxyge-
nases are also reported to form apocarotenoids (Yeum et al.,
1995). Other than the enzymatic cleavages, non-enzymatic
processes can also cause oxidative cleavages of carotenoids
to form various oxidative products (Nagao, 2004).
The enzymatic conversions of non-provitamin A carot-
enoids in humans and animals are still poorly understood.
Lycopene, a major non-provitamin A carotenoid has been
detected in human plasma and tissues. The unique chemical
property of lycopene is very sensitive to oxidative modifi-
cation/degradation in vivo (Britton, 1995; Siems,
Sommerbrug, & Van Kuijk, 1999). Understanding the
chemical structures of enzymatic/oxidative degradation
products of lycopene may help in ascertaining their health
benefits, which is yet to be addressed. In this context, thepossible formation of lycopene metabolites, also known
as lycopenoids are discussed. Studies have claimed the
presence of lycopene metabolites in serum and tissues at
physiologically significant levels in contrast to retinoids
(Nikki Ford & Erdman, 2012; Kopec et al., 2010). This
shows that the lycopene metabolites may be biologically
active, hence it is interesting to elucidate further the metab-
olites in humans and animals. Nevertheless, the identifica-
tion of enzymatic metabolites of lycopene in biological
fluids is highly critical. Breakdown of lycopene occurs
through isomerization followed by oxidation to form epox-
ides or undergoes eccentric cleavage by carotene-90,100-
monooxygenase (CMO-II) to form apo-lycopenals (Hu
et al., 2006; Wang, 2012). Earlier, Khachik et al. (1997)
identified lycopene oxidative product 2,6-cyclolycopene-
1,5-diol, in human serum and breast milk. Hu et al.
(2006) have demonstrated the formation of apo-100-lycope-
nal in the ferret. Further, they have confirmed that apo-100-
lycopenal was converted into apo-100-lycopenoic acid in
the presence of cofactor NADþ. Similarly, in the presence
of NADH lycopene was converted into apo-100-lycopenol
and apo-100-lycopenoic acid in ferret liver. Consequently,
Gajic, Zaripheh, Sun, and Erdman (2006) have determined
the existence of apo-80- and apo-120-lycopenal as well as
Table 1. Analytical techniques used for detection of carotenoid metabolites in biological samples.
Carotenoids Metabolites identifieda Biological samples Analytical method References
b-carotene b-apo-13-carotenone,
b-apo-140-carotenals & retinoids
Humans, monkey,
ferret and rat tissues
HPLC-UV-VIS Tang, Wang, Russell, and
Krinsky (1991); Wang,
Tang, Fox, Krinsky, and
Russell (1991)
Retinoic acid Ferret intestine HPLC-UV and GC/MS Wang and Krinsky (1997)
Retinol Human blood LC-MS (APCIþve) Wang et al. (2000)
(14) C-retinol,(14) C-b-apo-80-carotene Human plasma HPLC & accelerator MS. Ho, de Moura, Kim, and
Clifford (2007)
Vitamin A Human plasma LC/MS/MS Oxley et al. (2014)
Lycopene Epimeric 2,6-cyclolycopene-1,5-diols Human serum and
breast milk
HPLC-UV/visible-MS &
-NMR
Khachik et al. (1997)
Acycloretinoic acid Pig liver homogenates HPLC with GCeMS
analysis
Kim et al. (2001)
Apo-10-lycopenoids Ferrets RP-HPLC (C18 and C30) Hu et al. (2006)
Apo-80-lycopenal and Apo-120-lycopenal F344 rat liver HPLC-UV/VIS and ESIþve
mode
Gajic et al. (2006)
Apo-60-, Apo-80-, Apo-100-, Apo-120- &
Apo-140-lycopenals
Food sample and
human plasma
HPLC-MS/MS (APCIþve) Kopec et al. (2010)
Lutein and
Zeaxanthin
Geometric isomers of Lutein and
Zeaxanthin.
3-hydroxy-b, ε-caroten-30-one,
30-epilutein, ε,ε-carotene-3,30-diol,
ε,ε-carotene-3, 30-dione,
30-hydroxy-ε,ε-caroten-3-one, etc.
Human & Monkey
retina’s
HPLC (UV/Vis)-MS Khachik et al. (1997)
Lutein and zeaxanthin
stereoisomer’s
Retina HPLC-LC and HP
LC-NMR
Dachtler et al. (2001)
Lutein sterioisomers,
3-hydroxy-b, ε-carotene-30-one.
Human plasma, liver &
other ocular tissues/
Amphibians ocular tissues
HPLC Khachik et al. (2002)
(3R, 30S, 60R)-lutein (30-epilutein) Human serum, milk &
ocular tissues
HPLC-MS, 1H NMR Khachik et al. (1997);
Khachik (2003)
3-Hydroxy-b,ε-carotene-30-one
(30-oxolutein)
Human retina LC-MS (APCIþve) Bhosale and Bernstein
(2005)
Ethyl oximes of zeaxanthin oxidation
products
Eye samples HPLC-ESI-MS/MS MRM Prasain et al. (2005)
meso-Zeaxanthin, and 30-oxolutein Human macula HPLC & MS (APCIþve) Bhosale et al. (2007)
Lutein sterioisomers,
30-oxolutein, lutein epoxides, and
anhydrolutein
Rats plasma, liver and
eyes
HPLC and LC-MS
(APCIþve)
Lakshminarayana et al.
(2008)
30-hydroxy-ε,ε-caroten-3-one,
ε,ε-carotene-3,30-dione
Plasma and tissues of
ICR mice
HPLC-MS (APCI) Yonekura et al. (2010)
Astaxanthin 3-hydroxy-4-oxo-b-ion and
3-hydroxy-4-oxo-7,8-dihydro-b-ionone
Primary cultures of rat
hepatocytes
HPLC and GCeMS Wolz et al. (1999)
3-Hydroxy-4-oxo-b-ionol,
3-hydroxy-4-oxo-b-ionone,
3-hydroxy-4-oxo-7, 8-dihydro-b-ionol
and 3-hydroxy-4-oxo-7,8-dihydro-b-ionon
Humans plasma HPLC and GCeMS Kistler et al. (2002)
Fucoxanthin Fucoxanthinol and other metabolites White leghorn laying hens HPLC (VIS), MS, 1H NMR Strand et al. (1998)
Fucoxanthinol Male ICR mice plasma HPLC Sugawara et al. (2002)
Fucoxanthinol and amarouciaxanthin A Mice plasma and liver LC/MS with LCQ-MS Asai et al. (2004)
Fucoxanthinol, amarouciaxanthin A,
deacetylated, hydrolyzed & demethylated
fucoxanthin
Rats plasma HPLC and LC-MS (APCI) Sangeetha and Baskaran
(2010)
Fucoxanthinol and amarouciaxanthin A Plasma, liver, kidney and
adipose tissue of ICR mice
HPLC and LC-MS (APCI) Yonekura et al. (2010)
a For structures of metabolites refer Figs. 2 and 3.
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(2010) have shown a series of apo-lycopenals formation
in human plasma and concluded, metabolites are formed
either by enzymatic or chemical oxidative cleavage.Interestingly, a recent study indicated that apo-100- and
apo-140-lycopenoic acid have a remarkable ability to upre-
gulate BCO2 expression (Reynuld, Aydemir, Ruhl, Dagles,
& Caris-Veyret, 2011). The chemical structures of major
109B.P. Arathi et al. / Trends in Food Science & Technology 45 (2015) 105e117oxygenated carotenoids and their metabolites are shown in
Fig. 2.
Metabolism of oxygenated carotenoids
Lutein and zeaxanthin are two major oxygenated carot-
enoids found in plasma and tissues, and they are recognized
as macular pigments. Consumption of green leafy vegeta-
bles rich in lutein and zeaxanthin is reported to involve in
the delayed progression of age-related macular degenera-
tion and cataract (Bone et al., 2003). Krinsky, Landrum,
and Bone (2003) have postulated that macular pigments
improve acuity through amelioration effects of chronic ab-
erration and protect the central retina. Previously, studies
have shown the intestinal absorption and possible biotrans-
formation of lutein and zeaxanthin in vivo (Bone, Landrum,
Hime, Cains, & Zamor, 1993; Khachik, de Moura, Zhao,
Aebischer, & Bernstein, 2002; Lakshminarayana, Raju,
Krishnakantha, & Baskaran, 2006).
Apart from the dietary lutein and zeaxanthin, 30-epilu-
tein, 30-dehydrolutein, (3R,30S)-meso-zeaxanthin, 30-oxolu-
tein, 3-methoxy-zeaxanthin and other isomers/metabolites
have also been reported in human serum, milk and ocular
tissues (Khachik et al., 1997; Krinsky et al., 2003;
Bernstein et al., 2001; Bhosale, Zhao, Serban, &
Bernstein, 2007; Khachik, 1997; Bhosale & Bernstein,
2005). The Presence of these molecules indicates that
lutein/zeaxanthin undergoes various modifications under
in vivo conditions. Khachik et al. (1997) reported for the
first time and explained the formation of oxidation products
of lutein and zeaxanthin in human and monkey retinas. The
meso-zeaxanthin detected in human and monkey retina,
might be formed by double bond migration from lutein
(Bone et al., 1993). The dehydration products of lutein
such as, 3-hydroxy-30, 40-didehydro-b,g-carotene and 3-
hydroxy-20,30-didehydro-b,ε-carotene were thought to be
formed non-enzymatically in stomach under acidic condi-
tions (Khachik, Beecher, & Smith, 1995; Khachik, 2003).
In human tissues, metabolites of lutein 30-epilutein might
be formed by a back reduction of 30-oxolutein that was pro-
duced from lutein (Bone et al., 1993). Later, Yonekura,
Kobayashi, Terasaki, and Nagao (2010) have demonstrated
the conversion of lutein to keto-carotenoid 30-hydroxy-
ε,ε-carotene-3-one by oxidizing the secondary hydroxyl
group in mice model. It is hypothesized that lutein oxidized
products may be involved in the protection of eyes from ul-
traviolet rays. Epidemiological studies suggest that the
complete characterization of carotenoids and their metabo-
lites in the retina may help in understanding their functional
properties (Khachik, 1997).
Astaxanthin a keto-carotenoid, red fat-soluble pigment
present in various microalgae, certain microorganisms and
marine animals (Guerin, Huntley, & Olaizola, 2003). As-
taxanthin is considered as potent antioxidant molecule-
involves in the reduction of various diseases in animals
and humans (Higuera-Ciapara et al., 2006). Wolz, Liechti,
Notter, Oesterhelt, and Kistler (1999) demonstrated thatastaxanthin was metabolized into (rac)-3- hydroxy-4-oxo-
b-ionone and its reduced form (rac)-3-hydroxy-4-oxo-7,8-
dihydro-b-ionone independent of the xenobiotic-
metabolizing enzymes induced by astaxanthin in primary
cultures of rat hepatocytes. Kistler et al. (2002) reported
four radiolabeled metabolites including: 3-hydroxy-4-oxo-
b-ionol, 3-hydroxy-4-oxo-b-ionone, 3-hydroxy-4-oxo-7,
8-dihydro-b-ionol and 3-hydroxy-4-oxo-7,8-dihydro-b-ion-
one in human and primary human hepatocytes. Sangeetha
and Baskaran (2010) hypothesized that “non-provitamin
A carotenoids may yield retinol and confirmed that astaxan-
thin is converted into retinol via b-carotene in retinol-
deficient rats”. However, responsible enzymes for the for-
mation of astaxanthin metabolites and their biological func-
tions have not been elucidated. Canthaxanthinis another
keto-carotenoid pigment found in green algae, bacteria,
crustaceans and fish (Schwartzel & Cooney, 1972).
Tyczkowski, Yagen, and Hamilton (1988) revealed that a
portion of canthaxanthin was reduced to 4-
hydroxyechinenone (4-hydroxy-40-keto-beta, beta-caro-
tene) that in turn was reduced in part to isozeaxanthin
(4,40-dihydroxy-beta,beta-carotene) was confirmed by
high performance liquid chromatography analysis of tissues
from chicks. Bausch, Liechti, Oesterhelt, and Kistler (1999)
administered the radiolabeled non-provitamin A carotenoid
canthaxanthin and studied the urinary metabolic pattern in
rats, purification of the metabolite with HPLC, GCeMS
and NMR revealed that it was 3-hydroxy-4-oxo-7,8-
dihydro-beta-ionone.
Fucoxanthin a marine carotenoid found in brown sea-
weeds has notable biological properties. Several reports
have shown the potential role of fucoxanthin in human
health, such as antioxidant, anti-inflammatory, anti-cancer,
anti-obese, anti-diabetic, anti-angiogenic and anti-malarial
activities (Sachindra et al., 2007; Kim et al., 2010; Woo
et al., 2009). Reports have shown the formation of fucoxan-
thin metabolites and demonstrated the possible biological
activity in vitro and in vivo. It has been reported that fucox-
anthinol was detected in egg yolk of hens fed with brown
seaweeds (Fucus serratus and Fucus vesiculosus) (Strand,
Herstand, & Linaen-Jensen, 1998). Sugawara, Baskaran,
Tuzuki, and Nagao (2002) have shown the formation of fu-
coxanthinol in the intestinal tract and demonstrated the di-
etary fucoxanthin was deacetylated by lipase and esterase
from the pancreas or in intestinal cells. Asai, Sugawara,
Ono, and Nagao (2004) reported biotransformation of fu-
coxanthinol in ICR mice and HepG2 cells. In addition,
they also showed the bioconversion of fucoxanthinol into
amarouciaxanthin-A through dehydrogenation/isomeriza-
tion. It was found that fucoxanthinol and
amarouciaxanthin-A were detected in plasma and tissue
of ICR mice and retinol deficient rats fed with fucoxanthin,
whereas no fucoxanthin was detected (Hashimoto et al.,
2009; Sangeetha, Bhaskar, Divakar, & Baskaran, 2009b).
Sangeetha, Bhaskar, and Baskaran (2009) reported various
metabolites of fucoxanthin including fucoxanthinol and
Fig. 2. Chemical structure of hydrocarbon carotenoid. b-carotene (A) and lycopene (B) metabolites. Refer Table 1 for the details of biological samples
and analytical techniques used for their characterization.
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pathway of fucoxanthin in the plasma and liver of rats. In
addition, they have speculated the possible formation of
fucoxanthin metabolites through various enzymatic and
non-enzymatic reactions. Konishi, Hosokawa, Sashima,
Kobayashi, and Miyashita (2006) demonstrated the fucox-
anthinol was further metabolized into halocynthiaxanthin
in sea squirt (Halocynthia roretzi). The chemical structures
of major hydrocarbon carotenoids and their metabolites are
shown in Fig. 3.
Although, in vitro studies demonstrated that carotenoid
oxidation products exert effects that are either potentially
beneficial or detrimental to human health (Khachik et al.,
1995; Lakshminarayana et al., 2013; Zhang, Kotake-Nara,
Ono, & Nagao, 2003; Alija, Bresgen, Sommerburg, Siems,
& Eck, 2004; Hurst, Saini, Jin, Awasthi, & van Kuijk,
2005). Further, their active involvement in genetic regulation
and expression with respect to specific functions is deserved
to address health associated and nutrition-related disorders.
Hence, it is vital to assess the formation of carotenoids me-
tabolites/oxidative products and their cleavage/fragmenta-
tion pattern before understanding their biological function.
Therefore, optimization and validation of sensitive and spe-
cific analytical methods are essential to characterize carot-
enoid metabolites (Bhosale & Bernstein, 2005; Sowmya,
Arathi, Vijay, Baskaran, & Lakshminarayana, 2014)Techniques to characterize carotenoids and their
metabolites
Metabolomics are categorized into three approaches:
fingerprinting, profiling and targeted analysis. Finger-
printing compares the patterns of metabolites that change
in reaction to a specific function. Profiling focuses on the
analysis of a group of selected metabolites of interest.
The third approach would be targeted analysis of known
compounds such as carotenoids and their profile in different
groups of samples.
The diversified structural characteristic of dietary carot-
enoids requires an accurate method for their separation and
identification. Although, many chromatography techniques
are available for the determination of carotenoids in food
sources, and characterization is more challenging due to
similar molecular mass (structural isomers or geometrical
isomers) and other derivatives. Standardization of improved
chromatography techniques is evolved by their robustness,
speed of analysis and resolution. Henceforth, advancement
in mass spectrometry and revolution in liquid chromatog-
raphy with different stationary phase made it possible to
assess diversified carotenoids in a single platform. Analyt-
ical sensitivity and data processing for liquid chromatog-
raphy/mass spectrometry (LC/MS) have been
tremendously improved during last decade (Clarke,
Rindgen, Korfmacher, & Cox, 2001; Rivera, Vilaro, &
Fig. 3. Chemical structure of oxygenated carotenoid. Lutein (A) fucoxanthin (B) and astaxanthin (C) metabolites. Refer Table 1 for the details of bio-
logical samples and analytical techniques used for their characterization.
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carotenoid metabolites in complex biological fluids and tis-
sues continue to be a major task. Hence, we present the
recent advancement of chromatography, mass spectrometry
and their hyphenation technologies for carotenoid metabo-
lomics (Fig. 4).
Classically, TLC was used as a separation technique for
carotenoids with advantages of being fast, simple and low-
cost. There are two significant improvements in TLC,
HPTLC (reduction of the particle size and thickness) and
2D TLC (separation of samples in two orthogonal direc-
tions) to provide higher resolution (Rodic, Simonovska,
Albreht, & Vovk, 2012). However, the major limitation of
TLC is constrained by lower resolution, which considerably
hinders its applications. In addition, detection of caroten-
oids on TLC requires higher sample concentration. Since,
TLC operates in an open system, the compound is prone
to oxidation or degradation and hence, needs inert chamber
conditions. Further, separation of closely relatedcarotenoids needs more standardization of solvent ratios
for better separation and is time-consuming.
Routinely, HPLC with UVeVis upgraded with PDA/
DAD are used for the separation and quantification of carot-
enoids. These procedures made a provision to confirm the
existence of unknown carotenoids in a single run by
HPLC (normal or reversed-phase) systems under isocratic
or gradient elution. Previously, chromatographic separation
of carotenoids was based on HPLC analysis using C18 and
C30 columns. In general, C30 and C18 stationary phases are
extremely employed for the separation of geometrical iso-
mers (Bijttebier et al., 2014; Liu, Lee, Garofalo, Jenkins,
& EliSohemy, 2011). Advancement in Liquid chromatog-
raphy for separation of carotenoids and metabolites using
ultra high-performance liquid chromatography (UPLC)
are of current interest. Recently, UPLC-MS approaches
have been developed for the analysis of carotenoids in
foods and biological samples (Arathi et al., 2014;
Chauveau-Duriot, Doreau, Noziere, & Graulet, 2010;
Fig. 4. Strategies for detection and characterization of carotenoid metabolites using hyphenated techniques.
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The UPLC stationary phase consist of narrow-bore columns
packed with very small particles below 2 um and mobile
phase delivery systems operating at high backpressures
(103.5 MPa), While in conventional HPLC, the maximum
back-pressure is 35e40 MPa. Thus, UPLC offers several
advantages over conventional HPLC, such as rapid analysis
with shorter retention time, narrower peaks giving
increased signal-to-noise ratio with high resolution and
sensitivity. However, the drawback of UHPLC is currently
there is no C30 stationary phase, which is considered as a
’golden standard’ in the chromatographic separation of ca-
rotenoids (Bijttebier et al., 2014).
Generally, closely related carotenoids and their metabo-
lites co-elute in various analytical methods. Although, spec-
tral confirmation of these carotenoids are based on
characteristic UVeVis spectra obtained by PDA/DAD
and further characterization is required by MS analysis
(Frenich, Torres, Vega, Vidal, & Bolanos, 2005).
Directinfusion of carotenoids to MS do not require any
previous chromatographic separations. The method is accu-
rate, reproducible, highly sensitive and less time consump-
tion. But the limitation of this approach is ion suppression,
co-elution and formation of complex spectra of metabolites
that yield mass to charge ratio (m/z) (Draper, Lloyd,
Goodacre, & Beckmann, 2013).
GCeMS is another promising technique used to identify
the volatile compounds formed by enzymatic and non enzy-
matic oxidative degradation of carotenoids. However, there
are only a few reports on the analysis of carotenoids and
their metabolites by GCeMS. Novotny, Dueker, Zech,
and Clifford (1995) determined the metabolism of oral
fed b-carotene-d8 in plasma by HPLC, GCMS and
measured b-carotene-d8 and retinol-d4 concentrationetime
curves in humans. Wolz et al. (1999) investigated the astax-
anthin metabolites in primary cultures of rat hepatocytes by
GCeMS. Kim, Nara, Kobayashi, Terao, and Nagao (2001)analyzed the acycloretinoic acid formed by autoxidation of
lycopene in toluene by GCeMS. Aust et al. (2003) has re-
ported the biologically active lycopene oxidative product
2,7,11-trimethyltetradecahexaene-1,14-dial by using
GCeMS. The limitations of carotenoid analysis by
GCeMS are degradation under the high temperature, and
complex derivatization. The derivatization process may
significantly eliminate structural information of molecular
species.
There are remarkable milestones in the development of
analytical methods for qualitative and quantitative analysis
of carotenoids by LC-MS. Advancement of different ioni-
zation modes [EI; electron impact, FAB; fast atom
bombardment, MALDI; matrix-assisted laser desorption/
ionization, ESI; electrospray, APCI; atmospheric pressure
chemical ionization, APPI; atmospheric pressure photoion-
ization and ASAP; atmospheric pressure solids analysis
probe] in mass spectrometry are notable in carotenoids
biochemistry studies (Fraser et al., 2007; Kaufmann,
Wingerath, Kirsch, Stahl, & Sies, 1996; van Breemen,
1997; Crupi, Milella, & Antonacci, 2010; Van Breemen,
Dong, & Pajkovic, 2012). Most of the spectrometry anal-
ysis of carotenoids is acquired using positive ion mode.
APCI has become the most widely used ionization tech-
nique for various carotenoids because of high sensitivity
(Rivera et al., 2011). Several metabolites of carotenoids
were identified and characterized by using LC-MS in
APCI ionization mode (Lakshminarayana et al., 2008;
Bhosale et al., 2007; Yonekura et al., 2010; Asai et al.,
2004; Sangeetha et al., 2009a,b; Sicilia et al., 2005)
(Table 1). The main drawback of LC-MS is closely eluting
isobars, and isomers are indistinguishable by using this
method. Further, MSMS is a more reliable and selective
method for analysis of carotenoids. LC-MS/MS offers min-
imal sample size and distinguishes between co-eluted carot-
enoids and their metabolites, provides information about
structural isomers. MSMS is used in order to find out the
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induced dissociation (CID) of carotenoids. Fang,
Pajkovic, Wan, Gu, and van Breemen (2003) observed
that lycopene, b-carotene, and a-carotene produced molec-
ular ions of m/z 536 by LCeMS using APCIve analysis.
Prasain, Moore, Hurst, Barnes, and van Kuijk (2005) devel-
oped a sensitive and specific ESI-MSMS method for the
identification of two oxime derivatives of 3-hydroxy-b-ion-
one (m/z 252) and 3-hydroxy-140-apocarotenal (m/z 370)
with protonated molecules in a human eye sample. Van
Breemen et al. (2012) identified the characteristic fragment
ions of carotenes and selected xanthophylls using positive
and negative ions in APCI-MSMS, to distinguish between
carotenoids. Rivera, Christou, and Canela-Garayoa (2014)
determined the carotenoid content in transgenic maize
seeds and callus using UHPLC-APCIþve-MSMS. However,
MSMS produces identical fragmentation pattern of cis/
trans isomers of carotenoids due to switching of trans to
cis isomer under high probe temperature, hence a more sen-
sitive technique like ion mobility studies may help in
further differentiation of cis/trans isomers.
Ion mobility mass spectrometry (IMS) is the gas-phase
separation of ions in an electric field on the basis of size
and shape (Eiceman & Karpas, 2005). Due to thermal insta-
bility, carotenoids are isomerized during the ionization pro-
cess and IM-MS/MS separates cis/trans isomers. This
technique provides an opportunity to determine carotenoid
geometrical isomers based on its fragmentation pattern
formed during CID. Dong et al. (2010) characterized the
geometrical carotenoid isomers using travelling-wave ion
mobility spectrometry on a quadrupole time-of-flight
mass spectrometer. However, various cis isomers cannot
be resolved by using IMS.
Orbitrap MS is considered as a new tool, high-resolution
mass spectrometry for carotenoids analysis. Orbitrap detec-
tors are molecule screening detectors that can routinely
generate mass spectra with a resolving power up to 100
000 at full-width half maximum and mass accuracies within
two parts per million (ppm). Whereas, high mass resolution
and exact mass screening detectors enable the calculation
of the most probable molecular formulae of the ions and
fragments (Kind & Fiehn, 2006). This facilitates identifica-
tion of unknown compounds and helps in the elucidation of
fragmentation pattern. Bijttebier et al. (2014) reported for
the first time using orbitrap technology for the elucidation
of fragmentation pathways of carotenoids. More recently,
Van Meulebroek, Vanden Bussche, Steppe, and
Vanhaecke (2014) developed a full-scan high-resolution
metabolomic screening for carotenoids in tomato fruit by
using orbitrap-mass spectrometry.
One-dimensional LC is unsatisfactory when challenged
with highly complex samples, hence 2D LC has emerged
as a useful tool for carotenoid analysis. This provides an
extraordinary separation and resolution for analysis of com-
plex matrices. Carotenoids are analyzed in 2D by orthog-
onal dimension with reduced preparation steps whencompared to traditional HPLC methods. Herrero, Iba~nez,
Cifuentes, and Bernal (2009) highlighted multidimensional
chromatographic techniques and their main applications in
food analysis. 2D LC-MS may be considered as an useful
technique for carotenoid analysis, especially comprehen-
sive profiling of complex biological samples owing to its
predominant, sensitive and excellent resolution. Cacciola
et al. (2012) developed a comprehensive normal and
reversed-phase liquid chromatography and applied for anal-
ysis of the intact carotenoid composition of red chili pep-
pers, coupled with PDA and mass spectrometry. However,
the drawbacks of 2D LC are solvent incompatibilities and
immiscibility issues due to coupling of two different
columns.
Desorption electrospray ionization (DESI) and laser
ablation electrospray ionization (LAESI) are other two
novel ionization techniques that can be employed to study
carotenoid biochemistry. In comparison with ESI, DESI
can be used to determine biological samples directly
without complex sample pretreatment. This capability can
enhance the application field of DESI-MS in the analysis
of carotenoid. LAESI ionization technology was derived
from ESI, exciting the OH vibrations in water molecules
with a focused mid-IR laser beam in biological samples.
Takats, Wiseman, Gologan and Cookes (2004) observed
working under ambient conditions, DESI can be used for
the spatial analysis of native surfaces, such as plant or an-
imal tissues. The DESI spectrum collected from tomato
skin also indicates the localization of characteristic com-
pounds, including lycopene at m/z 536.
LC-NMR is a pioneering technique that offers 1-D and
2-D NMR spectra for the components separated by
HPLC. Recently, LC-NMR is widely used because of
improved sensitivity due to higher magnetic fields. Further,
NMR provides information about conformational geometry
for structural elucidation. LC-NMR is established as a
method of analyzing major carotenoids and metabolites in
food and biological samples (Tode, Maoka, & Sugiura,
2009). Dachtler, Glaser, Kohler, and Abert (2001) em-
ployed on-line HPLC-NMR coupling for the unambiguous
structural elucidation of lutein and zeaxanthin isomers at
low-nano moles range. NMR studies of the carotenoid me-
tabolites are difficult to be carried out due to the quantita-
tive limitation.
In spite of advancement in hyphenated techniques,
inconsistency of analytical results are possibly encountered
by several artifacts during the analysis of carotenoids and
their metabolites. The known pre-chromatographic errors
are due to types of samples or tissues, the nature of carot-
enoids, sample preparation, incomplete extraction, solvent
incompatibility, isomerization/oxidation, physical losses
of carotenoids/metabolites and its accountability. In LC-
MS or MS/MS analysis, the inaccuracy may arise due to
low recovery, less stability, inaccurate method validation,
co-elution, unavailability of standards, selection of
improper mode of ionization, carotenoid/metabolites with
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and optimization of analytical procedure/techniques,
adequate laboratory conditions such as protection from
light, circumvent high temperatures, avoid sample exposure
to atmospheric oxygen, preferably recommended to use
high purity solvents, proper storage under inert conditions
or it is recommended to analyze the samples immediately,
addition of antioxidants and completion of analysis within
shortest run time must be employed along with sophisti-
cated instruments (Rodriguez-Amaya, 2010).
Proposed future line of research
Till now, carotenoid research has typically focused on
characterization of carotenoids in food and various natural
sources. Currently, hyphenated analytical tools are also
applied for the identification of carotenoids and their me-
tabolites in body fluids and biological tissues. The compre-
hensive investigation of carotenoid metabolites drives
further progress to develop a novel or advance analytical
techniques for versatile analysis. The development of me-
tabolomics database and its integration into genomics, tran-
scriptomics, and proteomics have made links between
different levels of biological systems leading to understand-
ing systems biology. Furthermore, concept of metabolomics
helps to explore thousands of new components with benefi-
cial or harmful effects to humans. Notably, carotenoids are
rarely absorbed and excreted in their ingested forms, but
extensively metabolized in the body. The fate of metabo-
lites and its role in comparison with intact carotenoids
related to their health benefits needs to be addressed.
Although, sensitive analytical techniques are used for carot-
enoids analysis, further these techniques could also be
explored for metabolites too. Most of the bioactive
degraded/oxidized/metabolites of carotenoid products may
likely to have lesser life span, determination of such com-
ponents is really challenging. The acquiring of entire spec-
trum of metabolites and their characterization helps to
understand its structure-function relation. Hence, explora-
tion of a suitable analytical method with optimization, vali-
dation and reproducibility is required to reveal unknown
carotenoids and their metabolites.
Conclusion
Highly sensitive techniques are required to fingerprint
small molecules having superior biological significance.
The oxidative or cleavage products exist at picomolar range
and may be less stable with a shorter life. Hence, it is
important to analyze carotenoid metabolites quickly
without laborious preparation steps. HPLC, LC-MS and
NMR are widely used analytical techniques for the detec-
tion and quantification of carotenoids. Advancement in hy-
phenated techniques is applied to understand the
metabolism of carotenoids and identify its role in human
health and nutrition. Ongoing advances in techniques are
crucial for characterization and quantification of novel ca-
rotenoids in plants, microorganisms, seaweeds fornutritional and pharmaceutical purpose. Characterization
of food metabolomes leads to the discovery of food-
specific biomarkers, which are indicators of diet exposure
and food consumption. The dietary components influences
on carotenoids/metabolites bioavailability and its disposi-
tion at ultra trace level with targeted bioactivity need to
be addressed by using appropriate analytical methods.
Advancement in chromatography, mass spectrometry
and their hyphenation will help the scientists to gain a pro-
found insight into carotenoid biochemistry. Further, limited
dynamic range, lack of comprehensive coverage, and
limited annotations of carotenoid metabolites needs to be
addressed. The rapid analysis and minimized sample
requirement will gain the attention of researchers. Despite
the analytical advances, there is no single platform for
the analysis of carotenoids and their metabolites. The avail-
able data indicates that metabolomic studies require a uni-
versal protocol. Thus, for further approach a substantial
need for improvement to above limitations in carotenoid
metabolomics are warranted.
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